中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

55 records (took 0.029 seconds)

    TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS DGAT1 INHIBITORS
    1.
    发明申请
    TRIAZOLOPYRIDINE COMPOUNDS USEFUL AS DGAT1 INHIBITORS 审中-公开
    三唑并吡啶化合物作为DGAT1抑制剂有用

    公开(公告)号：WO2009126861A3

    公开(公告)日：2010-01-14

    申请号：PCT/US2009040163

    申请日：2009-04-10

    Applicant: SQUIBB BRISTOL MYERS CO ,  SUN CHONGQING

    Inventor： SUN CHONGQING

    IPC: A61K31/485 ,  C07D471/04

    CPC classification number: C07D471/04

    Abstract: Disclosed are triazolopyridine compounds of the following Formula (I); or stereoisomers or salts thereof. Also, disclosed are methods of using the compound in the treatment of obesity, dyslipidemia, diabetes and atherosclerosis, and to pharmaceutical compositions comprising at least one compound of Formula (I) or a stereoisomer or pharmaceutically acceptable salt thereof.

    Abstract translation: 公开了下式（I）的三唑并吡啶化合物; 或立体异构体或其盐。 还公开了使用该化合物治疗肥胖，血脂异常，糖尿病和动脉粥样硬化的方法，以及包含至少一种式（I）化合物或其立体异构体或药学上可接受的盐的药物组合物。

    PYRAZINE MODULATORS OF CANNABINOID RECEPTORS
    2.
    发明申请
    PYRAZINE MODULATORS OF CANNABINOID RECEPTORS 审中-公开
    大麻素受体的吡嗪类调节剂

    公开(公告)号：WO2005016286A3

    公开(公告)日：2005-06-09

    申请号：PCT/US2004026599

    申请日：2004-08-16

    Applicant: SQUIBB BRISTOL MYERS CO ,  ELLSWORTH BRUCE A ,  SUN CHONGQING ,  PENDRI ANNAPURNA

    Inventor： ELLSWORTH BRUCE A ,  SUN CHONGQING ,  PENDRI ANNAPURNA

    IPC: A61K20060101 ,  A61K31/4965 ,  A61K31/497 ,  C07D241/00 ,  C07D241/02

    CPC classification number: C07D241/24 ,  C07D401/06 ,  C07D401/14

    Abstract: The present application describes compounds according to Formula (I), wherein A, G , G and R are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula (I) both alone and in combination with one or more additional therapeutic agents.

    Abstract translation: 本申请描述了根据式（I）的化合物，其中A，G 1，G 2和R 1如本文所述。 此外，本申请描述了药物组合物，其包含至少一种根据式I的化合物和任选的一种或多种另外的治疗剂。 最后，本申请描述了单独使用式（I）化合物并与一种或多种另外的治疗剂组合治疗的方法。

    PYRAZINE MODULATORS OF CANNABINOID RECEPTORS
    3.
    发明申请
    PYRAZINE MODULATORS OF CANNABINOID RECEPTORS 审中-公开
    卡那霉素受体的吡嗪类调节剂

    公开(公告)号：WO2005016286A8

    公开(公告)日：2005-04-14

    申请号：PCT/US2004026599

    申请日：2004-08-16

    Applicant: SQUIBB BRISTOL MYERS CO ,  ELLSWORTH BRUCE A ,  SUN CHONGQING ,  PENDRI ANNAPURNA

    Inventor： ELLSWORTH BRUCE A ,  SUN CHONGQING ,  PENDRI ANNAPURNA

    IPC: A61K20060101 ,  A61K31/4965 ,  A61K31/497 ,  C07D241/00 ,  C07D241/02 ,  A61K

    CPC classification number: C07D241/24 ,  C07D401/06 ,  C07D401/14

    Abstract: The present application describes compounds according to Formula (I), wherein A, G , G and R are described herein. Additionally, the present application describes pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents. Finally, the present application describes methods of treatment using the compounds according to Formula (I) both alone and in combination with one or more additional therapeutic agents.

    Abstract translation: 本申请描述了根据式（I）的化合物，其中A，G 1，G 2和R 1在本文中描述。 另外，本申请描述了药物组合物，其包含至少一种根据式I的化合物和任选的一种或多种另外的治疗剂。 最后，本申请描述了使用单独的和与一种或多种另外的治疗剂组合的根据式（I）的化合物的治疗方法。

    BICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS
    4.
    发明申请
    BICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS 审中-公开
    作为大麻素受体调节剂的Bicyclic杂环

    公开(公告)号：WO2006076569A3

    公开(公告)日：2006-12-21

    申请号：PCT/US2006001213

    申请日：2006-01-12

    Applicant: SQUIBB BRISTOL MYERS CO ,  SUN CHONGQING ,  EWING WILLIAM R ,  HUANG YANTING ,  ZHU YEHENG

    Inventor： SUN CHONGQING ,  EWING WILLIAM R ,  HUANG YANTING ,  ZHU YEHENG

    IPC: C07D471/04 ,  A61K31/437 ,  A61K31/4375 ,  A61P3/04 ,  A61P25/34

    CPC classification number: C07D471/04 ,  C07D487/04 ,  C07D513/04

    Abstract: The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula (I): including all prodrugs, pharmaceutically acceptable salts and stereoisomers, R 1 , R 2 , R 3 , R 3a , R 4 , A, B, b, n, W, X, Y and Z are described herein.

    Abstract translation: 本申请描述了根据式I的化合物，包含至少一种根据式I的化合物和任选的一种或多种另外的治疗剂的药物组合物以及使用式I化合物单独治疗并且与一种或多种另外的 治疗剂。 所述化合物具有通式（I）：包括所有的前药，药学上可接受的盐和立体异构体，R 1，R 2，R 3，R 3， 本文描述了R 3，R 4，A，B，b，n，W，X​​，Y和Z.

    BICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS
    5.
    发明申请
    BICYCLIC HETEROCYCLES AS CANNABINOID RECEPTOR MODULATORS 审中-公开
    双相异构体作为CANNABINOID受体调节剂

    公开(公告)号：WO2006076598A3

    公开(公告)日：2006-08-24

    申请号：PCT/US2006001282

    申请日：2006-01-12

    Applicant: SQUIBB BRISTOL MYERS CO ,  SUN CHONGQING ,  EWING WILLIAM R ,  HUANG YANTING

    Inventor： SUN CHONGQING ,  EWING WILLIAM R ,  HUANG YANTING

    IPC: C07D471/04 ,  A61K31/4375 ,  A61P3/04

    CPC classification number: C07D471/04

    Abstract: The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula: (I); including all pharmaceutically acceptable salts and stereoisomers, R 1 , R 2 , R 3 , R 3a , R 4 , n, Y and Z are described herein.

    Abstract translation: 本申请描述了根据式I的化合物，包含至少一种根据式I的化合物和任选的一种或多种另外的治疗剂的药物组合物和使用根据式I的化合物的治疗方法，其单独和与一种或多种另外的 治疗剂。 化合物具有通式：（I）; 包括所有药学上可接受的盐和立体异构体，R 1，R 2，R 3，R 3，R 3， 本文中描述了SUP，4，n，Y和Z。

Patent Agency Ranking